ArriVent BioPharma, Inc. Common Stock (AVBP)

USD 18.39

(1.29%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021
Total Assets 163.09 Million 182.83 Million 43.04 Million
Total Current Assets 159.96 Million 182.62 Million 42.95 Million
Cash And Short Term Investments 150.38 Million 163.37 Million 37.28 Million
Cash and Cash Equivalents 150.38 Million 163.37 Million 37.28 Million
Short Term Investments - - -
Net Receivables 761 Thousand 500 Thousand 250 Thousand
Inventory - - -
Other Current Assets 8.81 Million 18.75 Million 5.42 Million
Total Non-Current Assets 3.13 Million 210.99 Thousand 88.99 Thousand
Net PPE 291 Thousand 139 Thousand -
Good Will And Intangible Assets - - -
Good Will - - -
Intangible Assets - - -
Long-Term Investments - - 2000.00
Tax Assets - - -
Other Non Current Assets 2.83 Million 71.99 Thousand 86.99 Thousand
Other Assets - 1.00 1.00
Total Liabilities 11.8 Million 8.37 Million 1.81 Million
Total Current Liabilities 11.62 Million 8.35 Million 1.81 Million
Account Payables 4.53 Million 3.09 Million 293 Thousand
Tax Payables - - -
Short Term Debt 140 Thousand 128 Thousand -
Deferred Revenue - -1.00 -
Other Current Liabilities 6.95 Million 5.13 Million 1.52 Million
Total Non Current Liabilities 176.99 Thousand 11 Thousand -
Long-Term Debt 177 Thousand 11 Thousand -
Deferred Revenue Non Current - - -
Deferred Tax Liabilities Non Current - - -
Other Non Current Liabilities -1.00 - -
Other Liabilities 1.00 1.00 -
Total Equity 151.29 Million 174.46 Million 41.22 Million
Stock Holders Equity 151.29 Million 174.46 Million 41.22 Million
Common Stock - 4000.00 4000.00
Retained Earnings -157.84 Million -88.51 Million -51.6 Million
Accumulated other comprehensive income - -4000.00 -4000.00
Common Stock Equity 151.29 Million 174.46 Million 41.22 Million
Capital Lease Obligation 177 Thousand 11 Thousand -
Total Investments - - 2000.00
Total Debt 317 Thousand 139 Thousand -
Net Debt -150.07 Million -163.23 Million -37.28 Million

Balance Sheet Charts